Vimarsana
Biggest News Aggregation in the World

John Wrangle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Wrangle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Wrangle Today - Breaking & Trending Today

Turning cancer scientists into entrepreneurs - Vimarsana News

Turning cancer scientists into entrepreneurs

MUSC Hollings Cancer Center is promoting entrepreneurship among its researchers.

Source: musc.edu
National Cancer Institute Selects ImmunityBio's N-803 IL-15 Receptor Agonist to Combine with Keytruda in 700-Site Lung-MAP Clinical Trial of a Chemo-Free Therapy - Vimarsana News

National Cancer Institute Selects ImmunityBio's N-803 IL-15 Receptor Agonist to Combine with Keytruda in 700-Site Lung-MAP Clinical Trial of a Chemo-Free Therapy

Lung-MAP trials are studying how well investigational or new drugs work in non-small cell lung cancer (NSCLC) patients and will study how N-803 (Anktiva) could bolster the current standard of care, checkpoint inhibitors.ImmunityBio’s study will test its IL-15 receptor superagonist complex N-803 (Anktiva) in combinat...

Winship, partners work to expand lung cancer services for veterans in the Southeast - Vimarsana News

Winship, partners work to expand lung cancer services for veterans in the Southeast

With new funding from the Veterans Affairs VA Lung Precision Oncology Program, Winship Cancer Institute of Emory University (Winship) will provide thoracic oncology expertise to help three VA medical centers expand access to high quality, disease altering lung cancer clinical trials to veterans in the Southeast. This five-year project is supported by $5 million in funding. It involves six investigators from three VA medical centers and their cancer centers partners. They are: Charleston/MUSC Hollings Cancer Center (Nichole Tanner, MD, MSCR; John Wrangle, MD), Birmingham/O’Neal Comprehensiv...

Source: emory.edu